肠道菌群
免疫疗法
癌症
化疗
佐剂
癌症治疗
免疫学
机制(生物学)
癌症免疫疗法
医学
免疫系统
生物
生物信息学
内科学
认识论
哲学
作者
Peng Cheng,Peiliang Shen,Yunlong Shan,Yu Yang,Rui Deng,Wenxing Chen,Yin Lu,Zhonghong Wei
标识
DOI:10.3389/fcell.2021.626045
摘要
The role of gut microbiota in the development of various tumors has been a rising topic of public interest, and in recent years, many studies have reported a close relationship between microbial groups and tumor development. Gut microbiota play a role in host metabolism, and the positive and negative alterations of these microbiota have an effect on tumor treatment. The microbiota directly promote, eliminate, and coordinate the efficacy of chemotherapy drugs and the toxicity of adjuvant drugs, and enhance the ability of patients to respond to tumors in adjuvant immunotherapy. In this review, we outline the significance of gut microbiota in tumor development, reveal its impacts on chemotherapy and immunotherapy, and discover various potential mechanisms whereby they influence tumor treatment. This review demonstrates the importance of intestinal microbiota-related research for clinical tumor treatment and provides additional strategy for clinical assistance in cancer treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI